Pith. sign in

REVIEW 3 major objections 5 minor 34 references

Geographically-dependent individual-level models for infectious diseases transmission

T0 review · 3 major / 5 minor · reviewed 2026-08-14 · deepseek-v4-flash

Pith's one-line read A disease model that adds location to individual-level transmission recovers hidden spatial risk from outbreak data.

desk verdict A useful but incremental extension of ILMs with a real identification problem in the applied distance-decay conclusion. read the letter →

arxiv 1908.06822 v1 pith:4TVKDBII submitted 2019-08-15 stat.AP physics.soc-phq-bio.PE

classification stat.APphysics.soc-phq-bio.PE MSC 62M3062F1592D3062P10
keywords individual-levelmodelsgeographically-dependentILMsconditionalautoregressivemodelBayesianinferenceMarkovchainMonteCarlospatialepidemiologyseasonalinfluenzainfectiousdiseasetransmission
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper generalizes individual-level models (ILMs) of infectious disease transmission so that a susceptible unit's infection probability can depend on where the unit is located, not only on how far it is from infectious units. The added ingredient is an area-level spatial random effect, modelled by a conditional autoregressive prior, which absorbs unobserved spatially structured risk factors or measurement error. The authors show by simulation that the geographically-dependent ILM can be fitted with MCMC and that the spatial effects are recoverable, then apply it to the 2009 Calgary seasonal influenza outbreak at the dissemination-area level. In that application, population size and latent area effects emerge as the main drivers of spread, while distance between area centroids appears to play little role.

What carries the argument

The load-bearing object is the spatial random effect $\varphi_k$ inside the susceptibility function $\Omega_S(i,k)=\exp(\alpha + X(i,k)'\alpha_1 + X(k)'\alpha_2 + X(k,t-\rho)'\alpha_3 + \varphi_k)$, with $\boldsymbol{\varphi}$ following the LCAR prior $\boldsymbol{\varphi}\sim \text{MVN}(0, \sigma^2[\lambda R + (1-\lambda)I]^{-1})$, where $R$ encodes first-order neighbourhood structure. This prior does the work of letting nearby areas share unexplained risk while allowing independent noise, and the spatial dependence parameter $\lambda$ controls the balance. Transmission between areas is handled by the power-law kernel $d_{ij}^{-\delta}$, and the region-restricted variant restricts infectious contacts to the same area and its neighbours, which is what keeps the MCMC likelihood computable.

What would settle it

Simulate an epidemic with a strong distance-decay kernel (large $\delta$) and recorded infection times equal to true infection times plus an area-dependent diagnosis lag; fit the GD-ILM using the recorded times. If the posterior $\delta$ shrinks toward the Calgary value near $0.134$ and the $\varphi_k$ absorb the lag pattern, the flat-distance result in the real data could arise from event-time misspecification alone.

Watch

Extended reading notes

Core claim

The central claim is that a previously defined discrete-time ILM, in which the infection kernel depends only on separation, can be replaced by a geographically-dependent ILM whose susceptibility term includes an exponentiated area effect $e^{\varphi_k}$. With $\boldsymbol{\varphi}=(\varphi_1,\ldots,\varphi_K)$ assigned an LCAR prior, the model can separate observable covariates, unobserved spatially structured risk, and distance-based transmission in a single Bayesian MCMC fit. The paper's simulation evidence shows that credible intervals cover the true values when the fitted and generating models agree, and that spatial random effects remain close to truth under weak, moderate, and strong spatial dependence; fitting a region-restricted model to globally generated data biases only $\delta$ downward. Applied to 2009 Calgary influenza data, the fitted SIR model gives a population-size coefficient of about $0.714$ and a distance-decay parameter of about $0.134$, leading the authors to conclude that population size and local-area random effects, not centroid distance, dominate local transmission.

Load-bearing premise

The likelihood treats infection and removal times as known; the Calgary application sets infection time to the first physician-visit diagnosis date and fixes the infectious period, so if the delay between true infection and diagnosis varies across areas, the distance and spatial-effect estimates are biased.

Editorial extensions

If this is right

  • In the Calgary SIR fit, the posterior mean population-size effect is $0.714$ with a 95% credible interval of roughly $0.619$ to $0.807$, so more populous dissemination areas contribute more to influenza pressure.
  • The small posterior distance-decay estimate, $\delta \approx 0.134$, implies nearly flat infection-probability curves over distances of a few kilometres, which the paper interprets as distance between area centroids being a weak predictor of early spread.
  • The posterior mean spatial effects separate clearly across the sixteen local geographic areas, so the model can rank areas by latent risk; the authors use these effects to construct posterior infectivity-rate risk maps for surveillance.
  • Simulations show that the region-restricted fitting procedure recovers parameters when the model is correctly specified, and that mismatch from a global generating model shows up mainly as downward bias in $\delta$.
  • Because the model is embedded in a Bayesian MCMC framework, the same machinery can be reused for other compartmental structures, such as SEIR or SIRS, without changing the core spatial-prior mechanism.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If true infection times lag first physician-visit dates by an amount that varies across areas, the infectious pressure assigned to $\delta$ and $\varphi_k$ would be redistributed; re-running the Calgary analysis with data-augmented infection times could either confirm or erase the flat-distance conclusion.
  • Because the units are dissemination areas rather than people, a fixed three-day infectious period at area level is a strong simplification; allowing within-area infection chains and variable infectious periods would test whether the distance effect remains small.
  • The posterior infectivity-rate risk maps suggest a direct prospective test: rank local geographic areas by posterior mean daily infectivity early in an outbreak and compare that ranking with subsequent laboratory-confirmed or physician-visit counts.
  • The same spatial-random-effect construction could be carried into epidemic forecasting models, where the posterior distribution of $\varphi_k$ would provide a data-driven prior for the next season's outbreak in the same set of areas.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 5 minor

Summary. The paper extends the individual-level models (ILMs) of Deardon et al. (2010) to a new class of geographically-dependent ILMs (GD-ILMs) that incorporate area-level spatial random effects via an LCAR prior. This allows the model to separate observable covariates (e.g., DA population size), unobserved spatially structured risk at the LGA level, and distance-based transmission. The model is fitted with MCMC (Gibbs sampling and Metropolis-Hastings), and its performance is explored through simulations under three scenarios: a matched region-restricted model (S1), and two mismatch scenarios (S2, S3) where data are generated from a global transmission model but fitted with the region-restricted model, the latter showing systematic underestimation of the spatial kernel parameter δ. The method is then applied to the 2009 Calgary seasonal influenza outbreak at the dissemination-area level under SI and SIR frameworks, with the key applied finding that population size matters but spatial distance does not. The paper also presents posterior infectivity risk maps for the 16 Calgary LGAs.

Significance. If the claims hold, the GD-ILM framework is a useful methodological extension of ILMs, allowing area-level spatial heterogeneity to be modelled in a Bayesian fashion. The simulation study in S1 shows that parameters are recovered in the matched setting, which is an important positive result, and the MCMC implementation is described in sufficient detail to be reproducible. However, the applied conclusion that spatial distance is not an important factor is not supported by the presented analysis: the paper itself demonstrates that fitting the region-restricted model to global-transmission data produces underestimates of δ of the kind observed in the Calgary application. The significance of the methodological contribution is real, but the application requires substantial revision before the main applied claim can be accepted.

major comments (3)
  1. [Section 3.4 vs Section 4.3] The simulation study shows that when the data-generating model is global (Eq. 8) but the fitted model is region-restricted (Eq. 7), δ is consistently underestimated. The application in Section 4 fits exactly this region-restricted model to the Calgary data, with no evidence that transmission is confined to adjacent LGAs; the Discussion itself notes high human mobility across the city. The posterior δ ≈ 0.134 (SIR; CI 0.012, 0.288) is then interpreted in Section 4.3 as evidence that 'spatial distance was not an important factor.' This is precisely the pattern the paper's own simulations predict under a global-transmission mechanism, so the small δ does not discriminate between 'no distance effect' and 'region-restricted model misspecified.' The authors should fit the global model (Eq. 8) to the real data, or provide a formal model comparison or a credible justification for the region-restricted assumption, before drawing the applied conclusion about δ.
  2. [Section 2.3 and Section 4.2] The likelihood in Eq. (5) is derived under 'Assuming known infection and removal times.' In the application, the time a dissemination area becomes infectious is set to the first physician-visit diagnosis date, with a fixed infectious period of 3 days (SIR) or the whole study window (SI), an assumption the authors call 'naive' at the DA scale in Section 4.2. If true infection times differ from diagnosis dates by a lag that varies across areas, the infection pressure aggregates in Eq. (3) are misaligned and the estimates of δ, α1, and the φ_k may be biased. The Discussion explicitly defers event-time uncertainty to future work; the applied numerical results should be presented with this caveat prominently attached rather than as unqualified estimates.
  3. [Section 4.3, Figure 9] The infectivity risk maps in Figure 9 are posterior summaries of the fitted model's own spatial random effects, so the ranking of LGAs is in-sample and not validated against external outcomes. The statement that these maps 'may be used to inform targeted surveillance' is a suggestion, not an evaluated property; it should be framed as such, or supported by an out-of-sample prediction exercise.
minor comments (5)
  1. [Figure 6 caption] Panel (b) of Figure 6 is labeled 'κ(i,j) vs distance' but the text describes it as the posterior predictive distribution of infection probability against distance; this mismatch should be corrected.
  2. [Section 2.2.1 and Section 2.2.2] There are typos: 'in the the GD-ILMs' should be 'in the GD-ILMs', and 'matix' should be 'matrix'.
  3. [Section 4.3] The posterior estimates of λ are very close to 1 (0.982 and 0.986), the intrinsic CAR boundary at which the LCAR model is improper; the authors should discuss the potential for boundary effects and whether the uniform prior on λ in the application is appropriate given the near-boundary estimates.
  4. [Section 3.3] The prior specification for α, α1, and δ as 'positive half-normal priors, each with mode 0 and variance 100' is incomplete; specifying the scale parameter of the half-normal distribution explicitly would aid reproducibility.
  5. [Abstract and Section 4.3] The abstract mentions 'predicting future disease progression' but the paper does not perform forecasting or out-of-sample prediction; the risk maps are retrospective summaries. The framing should be tempered or a forecasting exercise added.

Circularity Check

0 steps flagged · score 2.0 of 10

No circular reduction found; low score reflects minor self-citation and in-sample risk-map summaries, not a fitted-input prediction.

full rationale

The paper's derivation chain is self-contained: the GD-ILM likelihood (Eqs. 3-6) is built explicitly from the infection probability and MCMC posterior, and the simulation study checks parameter recovery rather than re-labelling fitted values as predictions. The application's risk maps (Figure 9) are posterior summaries of the model's own α1 and φ_k parameters, and the paper does not validate them against external outcomes, so no fitted input is presented as an independent prediction. Citations to Deardon et al. (2010) provide the base ILM and computational background; since Deardon is an author this is a self-citation, but it is not load-bearing for the new CAR extension, and no uniqueness claim is imported from it. The acknowledged limitations (event-time uncertainty, Section 4.2; region-restricted fitting) are correctness/identifiability concerns, not circularity: the paper's own S2/S3 finding that δ is underestimated under model mismatch is a real threat to the Calgary 'distance not important' conclusion, but it does not make the derivation equivalent to its inputs. Score 2 reflects the minor self-citation and in-sample nature of the risk-map rankings, not a circular step.

Assumptions & free parameters 7 free parameters · 6 assumptions · 0 invented entities

The central claim rests on familiar statistical machinery: the ILM infection probability form, the LCAR spatial prior, and the MCMC likelihood. The main paid-for inputs are modeling choices (power-law kernel, region-restricted neighborhood set, DA-level SIR/SI abstraction, fixed infectious period) and fitted parameters (α1, δ, λ, σ, φ_k). No new physical or ontological entities are introduced; the spatial random effects are standard latent variables without an independent falsifiable handle.

free parameters (7)
  • α (constant infectivity rate) = Set to 0 in the real-data analysis; 0.30 in simulations
    Baseline infectivity intercept. Chosen by hand to improve MCMC mixing of the spatial random effects (Section 4.2), absorbing some of the intercept structure into the random effects.
  • α1 (susceptibility covariate, DA population size) = 0.714 SIR (0.619, 0.807); 0.933 SI (0.837, 1.023)
    Central real-data finding: more populous dissemination areas promote transmission. Estimated by MCMC from the Calgary influenza data (Table 1).
  • δ (power-law kernel decay) = 0.134 SIR (0.012, 0.288); 0.149 SI (0.011, 0.334)
    Near-zero decay drives the conclusion that inter-DA distance is unimportant. Simulation truth was 4.0, and the paper's own S2/S3 simulations show δ is biased downward when the region-restricted model is fit to globally generated data.
  • λ (LCAR spatial dependence) = 0.986 SIR (0.974, 0.996); 0.982 SI (0.976, 0.999)
    Spatial dependence parameter in the LCAR prior. Posterior piles up near the improper intrinsic-CAR boundary λ=1 under a U(0,1) prior (Table 1).
  • σ (SD of spatial random effects) = 0.985 SIR (0.636, 1.519); 1.064 SI (0.694, 1.632)
    Variance scale of the LCAR random effects, updated via Gibbs sampling from an inverse-gamma full conditional (Section 3.3, Table 1).
  • φ_1,...,φ_16 (LGA spatial random effects) = Posterior means -5.91 to -4.44 (SI) and -4.61 to -3.24 (SIR)
    Latent spatial effects that generate the risk maps in Figure 9 and the claim of LGA-level heterogeneity. Estimated rather than independently measured.
  • γ (infectious period) = 3 days (SIR); whole study window (SI)
    Fixed by hand, not fitted. The authors acknowledge in Section 4.2 that γ=3 is 'naive' at the DA level because it implies one infected person per DA.
assumptions (6)
  • domain assumption Infection probability follows the discrete-time exponential form P = 1 - exp(-(rate + sparks)), Eq. (1) of Deardon et al. (2010).
    The GD-ILM inherits this functional form without independent derivation; it is taken from the cited prior framework.
  • domain assumption Infection and removal times are known when computing the likelihood (Section 2.3, Eqs. 5-6).
    The application substitutes first physician-visit dates for infection times and a fixed 3-day infectious period; the authors call the resulting assumptions naive in Section 4.2 and defer event-time uncertainty to future work in Section 5.
  • domain assumption Transmission risk from an infectious DA falls off as d^{-δ} (power-law kernel, Section 2.2.1).
    Choice of kernel family; only a robustness check with the Cauchy kernel is mentioned in the Discussion, with no results shown.
  • standard math Unobserved area risk follows the LCAR prior Φ ~ MVN(0, σ²(λR + (1-λ)I)^{-1}) (Appendix A, Eq. 9).
    Established Leroux et al. (1999) disease-mapping prior, imported without modification.
  • domain assumption Only infectious individuals in the same or bordering areas contribute to infection pressure in the region-restricted model (Eq. 2, neighborhood set ξ(k)).
    This computational restriction is also the source of the downward bias in δ under global transmission, demonstrated in the paper's own S2/S3 simulations (Section 3.4).
  • domain assumption Dissemination areas (400-700 people) act as single SIR/SI individuals with binary susceptible/infectious/removed status.
    The DA-level abstraction is the modeling unit; the covariate is DA population size from the 2011 census (Sections 3.2 and 4.1).

how reviews work

0 comments
Cite this review

Pith. "Pith review of Geographically-dependent individual-level models for infectious diseases transmission." pith.science (2026). https://pith.science/paper/4TVKDBII

@misc{pith2026190806822,
  author       = {Pith},
  title        = {Pith review of: Geographically-dependent individual-level models for infectious diseases transmission},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/4TVKDBII}},
  note         = {Machine review of arXiv:1908.06822}
}
read the original abstract

Infectious disease models can be of great use for understanding the underlying mechanisms that influence the spread of diseases and predicting future disease progression. Modeling has been increasingly used to evaluate the potential impact of different control measures and to guide public health policy decisions. In recent years, there has been rapid progress in developing spatio-temporal modeling of infectious diseases and an example of such recent developments is the discrete time individual-level models (ILMs). These models are well developed and provide a common framework for modeling many disease systems, however, they assume the probability of disease transmission between two individuals depends only on their spatial separation and not on their spatial locations. In cases where spatial location itself is important for understanding the spread of emerging infectious diseases and identifying their causes, it would be beneficial to incorporate the effect of spatial location in the model. In this study, we thus generalize the ILMs to a new class of geographically-dependent ILMs (GD-ILMs), to allow for the evaluation of the effect of spatially varying risk factors (e.g., education, environmental), as well as unobserved spatial structure, upon the transmission of infectious disease. Specifically, we consider a conditional autoregressive model to capture the effects of unobserved spatially structured latent covariates or measurement error. This results in flexible infectious disease models that can be used for formulating etiological hypotheses and identifying geographical regions of unusually high risk to formulate preventive action. The reliability of these models are investigated on a combination of simulated epidemic data and Alberta seasonal influenza outbreak data (2009). This new class of models is fitted to data within a Bayesian statistical framework using MCMC methods.

Figures

Figures reproduced from arXiv: 1908.06822 by the authors.

Figure 1
Figure 1. A subset of a realization of the epidemic progress maps made from [PITH_FULL_IMAGE:figures/full_fig_p012_1.png] view at source ↗
Figure 2
Figure 2. Results of the fixed effects parameter for all Simulation Scenarios (S1-S3), under [PITH_FULL_IMAGE:figures/full_fig_p014_2.png] view at source ↗
Figure 3
Figure 3. Results of the fixed effects parameter for all Simulation Scenarios (S1-S3), [PITH_FULL_IMAGE:figures/full_fig_p014_3.png] view at source ↗
Figures from the paper (8 more)
Figure 4
Figure 4. Figure 4: Results of the fixed effects parameter for all Simulation Scenarios (S1-S3), under [PITH_FULL_IMAGE:figures/full_fig_p015_4.png]
Figure 5
Figure 5. Figure 5: Results of a subset of spatial random effects ( [PITH_FULL_IMAGE:figures/full_fig_p015_5.png]
Figure 6
Figure 6. Figure 6: a shows the posterior mean of the probability of a susceptible DA i being infected from an infectious DA j over distance (dij ), for each of the 16 LGAs. Figure 6b shows the posterior predictive distribution of the probability of infection against distance (gray lines)…
Figure 7
Figure 7. Figure 7: A subset of the influenza epidemics during the period of October 25 - November [PITH_FULL_IMAGE:figures/full_fig_p018_7.png]
Figure 8
Figure 8. Figure 8: The probability of susceptible DA i being infected from infectious DA j across the 16 LGAs using median population size of DAs for each LGA against distance (in kilometers), (a) under the posterior mean where each line representing a different LGA; and (b) the gray lin…
Figure 9
Figure 9. Figure 9: The spatiotemporal distribution of posterior mean infectivity rates of influenza [PITH_FULL_IMAGE:figures/full_fig_p021_9.png]
Figure 10
Figure 10. Figure 10: A subset of a realization of the epidemic progress maps made from [PITH_FULL_IMAGE:figures/full_fig_p029_10.png]
Figure 11
Figure 11. Figure 11: A subset of a realization of the epidemic progress maps made from [PITH_FULL_IMAGE:figures/full_fig_p030_11.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

34 extracted references · 32 canonical work pages

  1. [1]

    Primary health care community profiles

    Alberta Health Services (2017). Primary health care community profiles. http://www.health.alberta.ca/services/PHC-community-profiles.html

  2. [2]

    Almutiry, W. (2018). Incorporating Contact Network Uncertainty in Individual Level Models of Infectious Disease within a Bayesian Framework . PhD thesis

  3. [3]

    and May, R

    Anderson, R. and May, R. (1991). Infectious Diseases of Humans . Oxford University Press, Oxford

  4. [4]

    and Andrews, J

    Basu, S. and Andrews, J. (2013). Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Medicine , 10(10):e1001540

  5. [5]

    A., Cornuet, J.-M., Marin, J.-M., and Robert, C

    Beaumont, M. A., Cornuet, J.-M., Marin, J.-M., and Robert, C. P. (2009). Adaptive approximate bayesian computation. Biometrika , 96(4):983--990

  6. [6]

    Besag, J. (1974). Spatial interaction and the statistical analysis of lattice systems. Journal of the Royal Statistical Society. Series B (Methodological) , pages 192--236

  7. [7]

    Besag, J., York, J., and Molli \'e , A. (1991). Bayesian image restoration, with two applications in spatial statistics. Annals of the Institute of Statistical Mathematics , 43(1):1--20

  8. [8]

    J., van Roermund, H

    Boender, G. J., van Roermund, H. J., de Jong, M. C., and Hagenaars, T. J. (2010). Transmission risks and control of foot-and-mouth disease in the netherlands: spatial patterns. Epidemics , 2(1):36--47

Show all 34 references
  1. [9]

    and Greenberg, E

    Chib, S. and Greenberg, E. (1995). Understanding the M etropolis- H astings A lgorithm. The American Statistician , 49(4):327--335

  2. [10]

    P., Grenfell, B

    Deardon, R., Brooks, S. P., Grenfell, B. T., Keeling, M. J., Tildesley, M. J., Savill, N. J., Shaw, D. J., and Woolhouse, M. E. (2010). Inference for individual-level models of infectious diseases in large populations. Statistica Sinica , 20(1):239

  3. [11]

    S., Carlin, J

    Gelman, A., Stern, H. S., Carlin, J. B., Dunson, D. B., Vehtari, A., and Rubin, D. B. (2013). Bayesian Data Analysis . Chapman and Hall/CRC

  4. [12]

    R., Ballesteros, S., Viboud, C., Simonsen, L., Bjornstad, O

    Gog, J. R., Ballesteros, S., Viboud, C., Simonsen, L., Bjornstad, O. N., Shaman, J., Chao, D. L., Khan, F., and Grenfell, B. T. (2014). Spatial transmission of 2009 pandemic influenza in the US . PLoS Computational Biology , 10(6):e1003635

  5. [13]

    Hastings, W. K. (1970). Monte C arlo sampling methods using M arkov chains and their applications. Biometrika , 57(1):97--109

  6. [14]

    He, D., Dushoff, J., Eftimie, R., and Earn, D. J. (2013). Patterns of spread of influenza A in C anada. Proceedings of the Royal Society of London B: Biological Sciences , 280(1770):20131174

  7. [15]

    P., Kypraios, T., Neal, P., Roberts, G

    Jewell, C. P., Kypraios, T., Neal, P., Roberts, G. O., et al. (2009). Bayesian analysis for emerging infectious diseases. Bayesian Analysis , 4(3):465--496

  8. [16]

    Keeling, M. J. and Rohani, P. (2011). Modeling I nfectious D iseases in H umans and A nimals . Princeton University Press: United States of America

  9. [17]

    Kwong, G. P. and Deardon, R. (2012). Linearized forms of individual-level models for large-scale spatial infectious disease systems. Bulletin of Mathematical Biology , 74(8):1912--1937

  10. [18]

    B., Banerjee, S., Haining, R

    Lawson, A. B., Banerjee, S., Haining, R. P., and Ugarte, M. D. (2016). Handbook of Spatial Epidemiology . CRC Press: New York

  11. [19]

    G., Lei, X., and Breslow, N

    Leroux, B. G., Lei, X., and Breslow, N. (1999). Estimation of disease rates in small areas: a new mixed model for spatial dependence. In Statistical Models in Epidemiology, the Environment, and Clinical Trials , pages 179--191. New York Springer

  12. [20]

    MacNab, Y. C. (2014). On identification in B ayesian disease mapping and ecological--spatial regression models. Statistical Methods in Medical Research , 23(2):134--155

  13. [21]

    Malik, R., Deardon, R., and Kwong, G. P. (2016). Parameterizing spatial models of infectious disease transmission that incorporate infection time uncertainty using sampling-based likelihood approximations. PloS one , 11(1):e0146253

  14. [22]

    Marjoram, P., Molitor, J., Plagnol, V., and Tavar \'e , S. (2003). Markov chain monte carlo without likelihoods. Proceedings of the National Academy of Sciences , 100(26):15324--15328

  15. [23]

    R., and Deardon, R

    McKinley, T., Cook, A. R., and Deardon, R. (2009). Inference in epidemic models without likelihoods. The International Journal of Biostatistics , 5(1)

  16. [24]

    J., Ross, J

    McKinley, T. J., Ross, J. V., Deardon, R., and Cook, A. R. (2014). Simulation-based bayesian inference for epidemic models. Computational Statistics & Data Analysis , 71:434--447

  17. [25]

    W., Rosenbluth, M

    Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., and Teller, E. (1953). Equation of S tate C alculations by F ast C omputing M achines. The Journal of Chemical Physics , 21(6):1087--1092

  18. [26]

    M., Folkers, G

    Morens, D. M., Folkers, G. K., and Fauci, A. S. (2004). The challenge of emerging and re-emerging infectious diseases. Nature , 430(6996):242--249

  19. [27]

    O'Neill, P. D. (2010). Introduction and snapshot review: relating infectious disease transmission models to data. Statistics in Medicine , 29(20):2069--2077

  20. [28]

    Palaniyandi, M., Anand, P., and Pavendar, T. (2017). Environmental risk factors in relation to occurrence of vector borne disease epidemics: Remote sensing and GIS for rapid assessment, picturesque, and monitoring towards sustainable health. International Journal of Mosquito R...

  21. [29]

    J., Parnell, S., Gottwald, T

    Parry, M., Gibson, G. J., Parnell, S., Gottwald, T. R., Irey, M. S., Gast, T. C., and Gilligan, C. A. (2014). Bayesian inference for an emerging arboreal epidemic in the presence of control. Proceedings of the National Academy of Sciences , 111(17):6258--6262

  22. [30]

    and Deardon, R

    Pokharel, G. and Deardon, R. (2016). Gaussian process emulators for spatial individual-level models of infectious disease. Canadian Journal of Statistics , 44(4):480--501

  23. [31]

    Riley, S. (2007). Large-scale spatial-transmission models of infectious disease. Science , 316(5829):1298--1301

  24. [32]

    Rue, H., Martino, S., and Chopin, N. (2009). Approximate B ayesian inference for latent G aussian models by using integrated nested L aplace approximations. Journal of the R oyal S tatistical S ociety: Series B ( S tatistical M ethodology) , 71(2):319--392

  25. [33]

    J., Shaw, D

    Savill, N. J., Shaw, D. J., Deardon, R., Tildesley, M. J., Keeling, M. J., Woolhouse, M. E., Brooks, S. P., and Grenfell, B. T. (2006). Topographic determinants of foot and mouth disease transmission in the UK 2001 epidemic. BMC Veterinary Research , 2(1):3

  26. [34]

    Dissemination area (DA)

    Statistics Canada (2016). Dissemination area (DA) . https://www12.statcan.gc.ca/census-recensement/2016/ref/dict/geo021-eng.cfm

Pith tools

Reviewed August 14, 2026 · model on record in the stance chip above.